Immune Checkpoint Inhibition as Single Therapy for Synchronous Cancers Exhibiting Hypermutation: An IRRDC Study.

Authors :: Henderson, Jacob J.
Das, Anirban
Morgenstern, Daniel A.
Sudhaman, Sumedha
Bianchi, Vanessa
Chung, Jill
Negm, Logine
Edwards, Melissa
Kram, David E.
Osborn, Michael
Hawkins, Cynthia
Bouffet, Eric
Cho, Yoon-Jae
Tabori, Uri
Source :: JCO Precision Oncology. 3/2/2022, Vol. 6, p1-5. 5p.
Publication Year :: 2022
Abstract: Two targets with one arrow: #Immunotherapy as single treatment for synchronous RRD #glioblastoma and #metastatic cancers. [ABSTRACT FROM AUTHOR]

Full Text Access

Tools